Director/PDMR Shareholding
12 June 2010 - 12:36AM
UK Regulatory
TIDMGWP
RNS Number : 5017N
GW Pharmaceuticals PLC
11 June 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 11 June 2010: GW Pharmaceuticals (AIM: GWP) hereby provides
notification that the Company has today been notified that on 9th June Dr
Geoffrey Guy, a Director and Executive Chairman of the Company, transferred
11,500 ordinary shares of 0.1p each, equating to 0.01% of the issued ordinary
share capital of the Company, into his personal pension scheme. Dr Guy also sold
30,000 ordinary shares of 0.1p each, equating to 0.02% of the issued ordinary
share capital of the company, at the market price of 115 pence per share.
Subsequently, Dr Guy has today exercised an option to acquire 50,000 ordinary
shares of 0.1p each, equating to 0.04% of the issued ordinary share capital at
an exercise price of 36.2 pence per share.
Following this notification Dr Guy's beneficial interest has increased to
18,343,952 ordinary shares, amounting to 14.12% of the shares in issue. The
total number of shares outstanding in the Company is 129,893,322 ordinary shares
of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44
(0)1980 557 000
Adam George, Company Secretary
Piper Jaffray Ltd (Nominated Adviser)
Neil Mackison/Rupert Winckler +44 (0)
203 142 8700
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFVSRIILLII
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles